Drug treatment of the complications of cirrhosis in the older adult

Drugs and Aging

Volumn 18, Issue 8, 2001, Pages 575-585

  Anand, Bhupinder S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRANCHED CHAIN AMINO ACID; BROMOCRIPTINE; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; DIURETIC AGENT; DOPAMINE; FUROSEMIDE; ISOSORBIDE MONONITRATE; LACTITOL; LACTULOSE; MIDODRINE; NADOLOL; NEOMYCIN; NORFLOXACIN; OCTREOTIDE; ORNIPRESSIN; SOMATOSTATIN; SPIRONOLACTONE; VANCOMYCIN; VASOCONSTRICTOR AGENT; VASOPRESSIN; ZINC;

AGING; ASCITES; BACTERIAL PERITONITIS; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; DIET RESTRICTION; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; ELDERLY CARE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVER WEIGHT; META ANALYSIS; PATIENT EDUCATION; PERITONEUM VEIN SHUNT; PORTAL HYPERTENSION; PRIORITY JOURNAL; REVIEW; SCREENING; SODIUM RESTRICTION; SURVIVAL; UREMIA; VARICOSIS;

EID: 0034877694     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200118080-00002     Document Type: Review

References (53)

1. The effect of age upon liver volume and apparent liver blood flow in healthy man
2. The formation of enlarged and giant mitochondria in the aging process of human hepatic cells
3. Age-related alterations in the size of the human hepatocytes: Study of mononuclear and binuclear cells
4. The aging gastrointestinal tract
5. The effect of increasing age on the distribution of peripheral blood flow in man
6. Parenchymal liver disease in the elderly
7. Haematological and biochemical laboratory values in an ambulatory elderly population: An analysis of the effects of age, sex, and drugs
8. Influence of age on secretion of cholesterol and synthesis of bile acids by the liver
9. Hepatic drug metabolism and aging
10. Drug therapy: Drug disposition in old age
11. Quantitative liver function in the liver assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance
12. Age-related decline in mitogen activated protein kinase activity in epidermal growth factor-stimulated rat hepatocytes
13. Senescent human fibroblasts resist programmed cell death, and failure to suppress bc 12 is involved
14. Natural history of liver fibrosis progression in patients with chronic hepatitis C
15. Cirrhosis
16. Renal sodium retention in cirrhosis: Tubular site and relation to hepatic dysfunction
17. Management of adult patients with ascites caused by cirrhosis
18. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome
19. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
20. The role of transjugular intrahepatic portosystemic shunting in patients with ascites
21. Short-course versus long course antibiotic treatment of spontaneous bacterial peritonitis
22. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis
23. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis
24. Diuresis of cirrhotic ascites increases its opsonic activity and may help prevent spontaneous bacterial peritonitis
25. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors
26. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo-controlled trial
27. Antibiotic prophylaxis for prevention of bacterial infections in cirrhotic patients with ascites: A meta-analysis
28. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with high risk of infection
29. Antibiotic prophylaxis for the prevention of bacterial infections in patients with cirrhosis after upper gastrointestinal bleeding: A meta-analysis
30. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document
31. Cost-analysis of prophylactic antibiotics in spontaneous bacterial peritonitis
32. Effects of oral ciprofloxacin on aerobic gram-negative fecal flora in patients with cirrhosis: Results of short- and long-term administration with daily and weekly dosages
33. Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: Effect of long-term administration of norfloxacin
34. The treatment of portal hypertension: A meta-analytic review
35. Prevention of first bleeding in cirrhosis: A meta-analysis of randomized trials of nonsurgical treatment
36. The course of patients after variceal hemorrhage
37. Controlled trial of injection sclerotherapy for active variceal bleeding
38. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding
39. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: A meta-analysis
40. Nadolol plus isosorbide mononitrate compared with sclerotherapy for prevention of variceal rebleeding
41. Reversal of Type 1 hepatorenal syndrome with the administration of midodrine and octreotide
42. Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
43. Transjugular portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems
44. Incidence, predictive factors and prognosis of the hepatorenal syndrome in cirrhosis with ascites
45. Animal versus vegetable protein diet in hepatic encephalopathy
46. Lactilol in treatment of chronic hepatic encephalopathy: A meta-analysis
47. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: A double blind controlled trial
48. Rising incidence of hepatocellular carcinoma in the United States
49. Liver disease in the elderly
50. Hepatic resection for hepatocellular carcinoma in the elderly
51. Tumors of the liver
52. Correlation between donor age and the pattern of liver graft recovery after transplantation
53. Implications of advanced donor age on the outcome of liver transplantation